The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lasofoxifene (LAS) plus abemaciclib (Abema) for treating ESR1-mutated ER+/HER2- metastatic breast cancer (mBC) after progression on prior therapies: ELAINE 2 study update.
 
Senthil Damodaran
Consulting or Advisory Role - Taiho Oncology
Research Funding - AstraZeneca (Inst); EMD Serono (Inst); Guardant Health (Inst); Novartis (Inst); Sermonix Pharmaceuticals (Inst); Taiho Pharmaceutical (Inst)
 
Halle C. F. Moore
Consulting or Advisory Role - Myovant Sciences
Research Funding - AstraZeneca (Inst); Daiichi Sankyo (Inst); Roche (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst)
 
Ian Churchill Anderson
Research Funding - Abbvie (Inst); Apollomics (Inst); AstraZeneca (Inst); EMD Serono (Inst); Hutchison MediPharma (Inst); Merck (Inst); Seagen (Inst); Turning Point Therapeutics (Inst)
 
Mathew Amprayil Cherian
No Relationships to Disclose
 
Ciara Catherine O'Sullivan
Honoraria - AstraZeneca (Inst); Seagen (Inst); Seagen (Inst)
Research Funding - Academic & Community Cancer Research United (Inst); Bavarian Nordic (Inst); Eisai (Inst); Genentech (Inst); Lilly (Inst); nference (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - nFerence Astra Zeneca (Inst)
 
Paul V Plourde
Employment - Sermonix Pharmaceuticals
Stock and Other Ownership Interests - Sermonix Pharmaceuticals
 
David Jay Portman
Employment - Sermonix Pharmaceuticals
Leadership - Sermonix Pharmaceuticals
Stock and Other Ownership Interests - Sermonix Pharmaceuticals
Consulting or Advisory Role - Agile Therapeutics; Sebela Pharma
Other Relationship - Sermonix Pharmaceuticals (I)
 
Matthew P. Goetz
Consulting or Advisory Role - ARC Therapeutics (Inst); AstraZeneca (Inst); bioTheranostics (Inst); Blueprint Medicines (Inst); Genzyme (Inst); Lilly (Inst); Rna Diagnostics (Inst); Seagen (Inst)
Research Funding - Lilly (Inst); Pfizer (Inst); Sermonix Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Development of Human Tumor Xenografts from Women with Breast Cancer Treated with Neoadjuvant Chemotherapy (Inst); Methods and Materials for Assessing Chemotherapy Responsiveness and Treating Cancer; METHODS AND MATERIALS FOR USING BUTYRYLCHOLINESTERASES TO TREAT CANCER
Travel, Accommodations, Expenses - Lilly